The present investigation was undertaken with the objective of developing fast dissolving film(s) of a tricyclic antidepressant drug amitriptyline hydrochloride in order to improve its bioavailability, optimize its therapeutic action especially when used to treat major depression and to enhance the compliance for the developmentally disable, mentally ill, elderly and pediatric patients. Fast dissolving dosage forms have acquired great importance in pharmaceutical industry because of their unique properties. Ten formulations were prepared by solvent casting method using different polymer types, plasticizer types, surfactant concentrations and different ratio of hydroxypropyl methyl cellulose and maltodextrin. The prepared films were evaluated for folding endurance, thickness, drug content, in vitro/in vivo disintegration time, drug release and tensile test. The optimized formula F8 containing HPMC 15cp and maltodextrin in 1:1 ratio showed minimum in vitro/in vivo disintegration time 16.8, 13.2 seconds respectively, highest dissolution rate i.e. T80%
Introduction
Despite the tremendous advancement in the drug delivery system, oral route is the most acceptable drug delivery route for patient compliance aspects. There are many drug delivery systems accessible for the oral administration of the drugs. All these systems are related with their own merits and demerits The strips may be flexible or brittle, transparent or opaque which is simply placed on the tongue or any oral mucosal tissue and due to saliva, it instantly wet, hydrates and adheres onto the site of application. It rapidly disintegrates and dissolves to release the drug for oromucosal absorption or will maintain the quick-dissolving aspects which allow for gastrointestinal absorption to be achieved when swallowed. Fast dissolving films provide rapid, precise dosing in a safe, efficacious format that is convenient, portable and can be used anywhere anytime 4 . Amitriptyline hydrochloride (AMT HCl) is a tricyclic antidepressant, which is widely prescribed for the treatment of major depression. It has low bioavailability (30-60%) due to extensive first-pass effect 5 . The aim of this study was to formulate Amitriptyline Hydrochloride as fast dissolving films, to improve the pharmacokinetic properties of the drug through enhancing the rate of drug absorption, avoiding hepatic first -pass metabolism and to provide effective and satisfactory dosage form for patients suffering from dysphagia, nausea or vomiting and unconscious patients.
Materials and Methods

Materials
Amitriptyline HCl (Samara drug industry-Iraq) Hydroxy propyl methyl 
Methods
Preparation of oral film
Ten formulations were prepared (F1-F10), using solvent casting method with different types of polymers and composition as shown in table 1. The plasticizer, sodium saccharine, citric acid and mannitol were dissolved in suitable volume of water with heating and continuous stirring to form a clear viscous solution. After cooling, a suitable amount of polymers (an aqueous dispersion of film forming polymer was separately prepared) were added to the previous solution. Pre-dissolved AMT HCl in water was added with stirring for 4 hours, until uniformly viscous solution achieved, which was kept undisturbed condition at least for 24 hours to remove the entrapped air. The resulting solution was poured into a 9 cm petri dish and allowed to dry in hot air oven at 40 ºC for 24 hours, the dried batch carefully removed, cut into desired size 6 .
Evaluation of oral films
Visual inspection
Properties such as homogeneity, color, transparency and surface of the oral films were inspected for all the prepared oral films 7 .
Thickness measurements
The thickness of the film was measured by micrometer screw gauge at different strategic points. Each film was measured at 5 positions (center and four corners), and the mean thickness was calculated 8 .
Drug Content Uniformity
The film was allowed to dissolve in 100 ml phosphate buffer pH 6.8 contained in 100 ml volumetric flask, with stirrer maintained at 37°C for 3 hours and left for 24 hr at room temperature. The filtered solution was diluted and analyzed by UV-spectrophotometer at λmax 239 nm in triplicate, the average drug content was calculated 9 .
Surface pH study
The surface pH of the oral dissolving film is calculated in order to investigate the risk of any side effects in vivo, since acidic or alkaline pH may cause irritation to the oral mucosa and it is measured to maintain the surface pH as close to neutral as possible. A combined pH electrode is used for this purpose. The film was slightly wet with the help of 1 ml of distilled water and kept for 30 seconds. The pH was measured by bringing the electrode in contact with the surface of the formulation and allowing it to equilibrate for 1 minute. The average of three determinations for each film was determined 10 .
Folding endurance
The folding endurance is expressed as the number of folds (number of times of folding the film at the same plain) required to break the specimen or developing visible cracks or folded up to 300 times manually, which was considered satisfactory to reveal good patch properties and gives an indication of brittleness of the film 11 .
Tensile test
The mechanical properties of the films were determined using tinius Olsen testing instrument (Model H50KT, UK). The sample was cut into a dumbbell shape, then held between two clamps and the strip was pulled by the top clamp at a rate of 10 cm/min. The force and elongation were determined as the film broke. The mechanical properties include tensile strength, percent elongation, elastic modulus and strain were computed for the characterization of the film 12 . Tensile strength is the maximum stress applied to a point at which the strip specimen breaks 
.1 In-vitro disintegration test
The test was performed using USP disintegration test apparatus, using 250 ml phosphate buffer pH 6.8 at 37±0.5°C as medium, 2×2 cm 2 film was placed in the tube of the basket and the disks were placed over it 15 .
In-vivo disintegration test
The time required for complete disintegration in the oral cavity was calculated from three healthy volunteers. The mouth cavity was rinsed with a cup of water, the film was placed on the tongue and subsequently the tongue was gently moved. The time required for disintegration in the mouth was determined. The data were represented as a mean of three replicate determinations 16 .
In-vitro dissolution study
The dissolution study was carried out using USP dissolution apparatus type II paddle apparatus in 250 ml phosphate buffer (pH 
Characterization of selected formula using scanning electron microscopy (SEM)
SEM (SEM Inspect S50-Netherlands) is utilized to assess the surface morphological characteristics of the optimized formulation.
The sample for SEM was mounted on round brass stub using double backed adhesive tape and then sputter coated for 30 seconds with gold palladium under an argon atmosphere. The stub containing the coated sample was placed in the scanning electron microscope chamber. Microphotographs were taken on different magnification 17 .
Bioavailability test 2.2.3.9.1 Study design
The protocol for the study was approved by the animal care committee in National Center for Drugs Control and Researches in Iraq. Twenty four male rabbits (weighed 1850-2250 g) were selected
for this study and only 6 rabbits continued in this study because of several difficulties such as (disease, death of animals during the study and difficulty to continue sampling as decided schedule times).
All six rabbits were healthy during the period of the experiment. The study was a simple crossover design with three-week washout period, in order to reduce variability arising from physiological variables (e.g. gastric emptying, pH), in addition to the variability arising from residual effects. The rabbits were fasted overnight (to minimize the effects of food on pharmacokinetic profile) with free access of water and single dose 40 mg /kg was administered. The rabbits were randomly divided into two groups (A and B) each group consist of three rabbits. Group A were anesthetized by intravenous injection of pentobarbital in a dose of 25 mg/kg, the rabbits were then placed on a table with the lower jaw supported in a horizontal position and the selected formula F8 was placed carefully on the rabbit's tongue. The rabbits were anaesthetized to ensure the maintenance of the film in the oral cavity without escaping down the gastrointestinal tract. A suitable volume of the commercial AMT HCl solution equivalent to the applied dose was administered orally to group B via gastric gavage 18, 19 . Blood samples (2ml) were drawn from the marginal ear vein at zero time and 1, 2, 3, 4, 6, 8, 10 and 24
hours .Blood samples were collected in heparinized tubes and immediately frozen at-20°C until analysis 20 .
Chromatographic conditions
A Knauer HPLC system (Germany) was employed in the bioavailability test and consists of a Wellchrom K-1001 pump, a
Rheodyne 7125 injector and a K 2501 UV detector with a thermostatic column compartment connected to a Eurochrom 2000
injector. An isocratic high performance liquid chromatography was performed on an analytical C18 column (Knaure;150 ×4.6 mm ;5 μm particle size; 25cm length ) supported by guard column C18-4 mm diameter (Germany).The wave length was set at 254 nm. The mobile phase was a mixture of acetonitrile and buffer solution of (0 .02 M) KH2PO4 (35: 65 v/v) and adjusted to pH 3.0 by orthophosphoric acid.
Chromatographies were carried out using flow rate of 1.5 ml min -1 and at 40°C 21 .
Preparation of stock solutions
The primary stock solutions of AMT HCl standard and internal standard (I.S) diltiazem HCl were prepared by dissolving separately 10 mg of each compound in 10 ml of methanol using volumetric flasks, to produce concentration of 1 mg/ml. These were stored at -20°C. The working standard solution of the strength 10μg /ml was prepared by diluted the stock solution 100 fold via using the mobile phase 22 .
Sample extraction procedure
To one milliliter of blood, 50 µl of I.S (10µg/ml freshly prepared) and 200 µl of 0.5 M NaOH were added together with 4 ml n-hexane. The 
Pharmacokinetic and statistical calculations
The peak concentration (Cmax) and peak times (Tmax) were derived directly from the experimental points. The other pharmacokinetic parameters of two formulations were computed by noncompartmental analysis using (Kinetica® software-version 5, Thermo
Fisher scientific, USA), mean value (±SD) were calculated for each parameter. The pharmacokinetic parameters of the two products (the prepared film and commercial solution of AMT HCl) were compared by one way analysis of variance (ANOVA).
Results and Discussions
Visual inspection
The appearance of all prepared AMT HCl fast dissolving films which contain different film forming polymers showed homogenous, transparent, flexible, non sticky, smooth in the texture properties with elegant appearance. 
Drug content uniformity
All the prepared films were found to be within uniform quantity of the drug, and the preparations met the criteria of United State Pharmacopeia (USP), as shown in table 2 . This indicates that the drug was uniformly dispersed throughout the films 24 .
Surface pH study
The surface pH of films was found to be in the range of (6.1 -6.89), which is within the range of salivary pH. It indicates that the fast dissolving film not create any types of oromucosal irritation.
Folding endurance
The results indicated that most of the formulas showed satisfactory folding endurance, the low folding endurance of the films below the acceptable level (usually ˂100 times) were found in the formulations (F10), this is related to weak bonds between polymer chains that cannot maintain their integrity upon folding25,as shown in table 2.
Effect of film forming polymer types
Formulations (F1-F3) that were prepared using different primary film forming polymers (HPMC 15cp, PVA, NaCMC) to study the effect of The results display the effect of film forming polymer types on the mechanical properties of the prepared films (F1-F3), formula F1 gave satisfactory mechanical property. Formula F2 showed higher strain, higher TS, higher E% than F1, this may be due to formation of strong hydrogen bonds between polymer (PVA) and plasticizer there by imparting the polymer flexibility to withstand rupture 27 . While F3
showed lower strain value, as shown in table 3.
The effect of changing types of the polymer on the drug release profile from AMT HCl fast dissolving films was conducted by comparing the release profile of formulations (F1-F3) as shown in figure 1 . The time required for 80% of drug to be released (T80%) and percent drug dissolved in 2 minutes (D2 min) are scheduled in table 4.
Formulation F2 showed higher dissolution rate than other formulas, this is attributed to the high solubility of PVA in water, and the loosely bounded PVA molecules were easily eroded, allowing the rapid release of the drug 28 .while Formula F4 showed lower dissolution rate since Na CMC dissolved rapidly leading to the formation of channels inside the matrix of the film which enhanced the diffusion of the drug a cross such channels followed by the formation of a stable gel layer which in turn will control the release of drug from the film 29 . 
Effect of incorporation of different concentrations of surfactant (Tween 80)
The effect of different concentrations of surfactant, 2.5% (F6) and 5% (F7) in comparison to F1 (not contain surfactant ) on the disintegration time, mechanical properties and in-vitro drug release profile of AMT HCl oral films were studied. Table 3 revealed that, the increase in concentration of tween 80 caused significant reduction (p<0.05) in disintegration time, since tween 80 is emulsifying agent, so it facilitates the diffusion of fluid into the film resulting in faster disintegration of the film 33 . Therefore formulation F7 disintegrated faster than F6 and F1. and 5% (F7) significantly improved (p<0.05) the mechanical property of the prepared films. Since the presence of tween 80 will alter the structure and form porous and less dense polymer structure and hence the TS decreased 34 . Table 4 and Figure 3 shown that F7 gave fastest dissolution rate, this may be due to the ability of the surfactant to improve wettability of the film and reduced the surface tension, making the drug easily accessible by dissolution medium, immediately dissolves and diffuses from the interface between the film surface and the surrounding medium 35 .
Effect of polymeric blend and polymeric blend ratio
Formula F7 (not contain MDX), F8 (contain HPMC:MDX in the ratio 1:1) , F9(contain HPMC:MDX in the ratio 2:1) in addition to F10 ( contain HPMC:MDX in the ratio 1:2) were used to study the effect of polymeric blend and the polymeric blend ratio on the in vitro/in vivo disintegration time, mechanical properties and in-vitro drug release profile of AMT HCl oral films. Table 3 shows an enhancement in the disintegration time with the addition of MDX compared with formula without MDX, this could be attributed to the presence of MDX in the formulation that facilitates water penetration into the film structure due to its high watersolubility, leading to decrease the thickness of the films and reduced the DT 
Bioavailability test
The concentration of AMT HCl in rabbits blood was determined using a reproducible, sensitive and rapid HPLC method, which showed two separated peaks chromatogram for AMT and internal standard 
Conclusions
In vitro and in vivo evaluation of the AMT HCl fast dissolving films confirmed their potential as an innovative dosage form to improve delivery of amitriptyline hydrochloride. Therefore, the oral fast dissolving film is considered to be potentially useful for the treatment of disease where the quick onset of action is desired, also improved patient compliance. NKM, MGA, MMG and ZDS participate in bioavailability study.
ZDS carried out the formulation of FDF of AMT HCl, in vitro evaluation and the bioavailability study.
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